Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Ftase inhibitors(Protein farnesyltransferase inhibitors), RAS inhibitors(RAS type GTPase family inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H25N3O3S2 |
InChIKeyYUXOGMIOPNYIQR-DYVFJYSZSA-N |
CAS Registry174639-12-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | FR | - |